首页|基于"互联网+"药学服务模式提升口服抗肿瘤药物用药安全研究

基于"互联网+"药学服务模式提升口服抗肿瘤药物用药安全研究

扫码查看
目的 探索基于"互联网+"药学服务模式在提升口服抗肿瘤药物用药安全当中的作用.方法 选取我院 2022 年3 月至10 月服用口服抗肿瘤药物的患者80 例,其中40 例接受了基于"互联网+"的药学服务,为观察组;另40 例接受了常规的药学服务,为对照组.比较两组的用药依从性、错误用药发生情况、用药健康知识掌握程度及患者满意度.结果 观察组依从性良好率为 92.5%,对照组依从性良好率为82.5%,两组间依从性比较差异具有统计学意义(P<0.05);观察组总共发生3 例次用药错误,对照组为 10 例次,观察组明显低于对照组(P<0.05);两组患者的用药健康知识掌握程度评分在药学干预后均有所升高,且观察组明显高于对照组(P<0.05);观察组的药学服务满意度为100%,对照组为96.7%(P>0.05).结论 基于"互联网+"药学服务模式可提升居家患者用药依从性,减少用药错误发生率,提高患者的用药健康知识,从而提升口服抗肿瘤药物用药安全.
Research on Improving the Safety of Oral Antitumor Drugs Based on"In-ternet+"Pharmaceutical Care Model
OBJECTIVE To explore the role of"Internet+"pharmaceutical care model in improving the safety of oral antitumor drugs.METHODS Eighty patients who took oral antitumor drugs in our hospital from March to October 2022 were selected,40 of them received pharmaceutical care based on"Internet+"as the observation group;the other 40 patients received regular pharmaceutical care and served as the control group.The medication compliance,occurrence of medication errors,mastery of medication health knowledge and patient satisfaction were compared between the two groups.RESULTS The good compliance rate of the observation group was 92.5%;while the control group was 82.5%,and the difference between the two groups was statistically significant(P<0.05).Medication errors occurred for 3 times in the observation group and 10 times in the control group,the observation group was significantly lower than that in the control group(P<0.05).The score of health knowledge of medication was increased in both groups after intervention,and the observation group was significantly higher than the control group(P<0.05).The satisfaction of pharmaceutical care was 100%in the obser"Internet+"pharmaceutical care model,the medication compliance of home patients can be improved,the incidence of medication errors can be re-duced,and the medication health knowledge of patients can be improved,thus improving the medication safety of oral antitumor drugs.

Internet+Pharmaceutical careAntitumor drugSafety of medication

向露、唐玥璐、廖翠、胡小刚

展开 >

重庆大学附属肿瘤医院药学部,重庆 400030

互联网+ 药学服务 肿瘤药物 用药安全

2024

海峡药学
中国药学会福建分会

海峡药学

影响因子:0.643
ISSN:1006-3765
年,卷(期):2024.36(5)